Stroke risk assessment in atrial fibrillation

Stavros Apostolakis*, Gregory Y H Lip

*Corresponding author for this work

Research output: Chapter in Book/Report/Conference proceedingChapter

Abstract

Atrial fibrillation is associated with increased risk for thromboembolism. The risk of atrial fibrillation-related thromboembolism is not homogenous and it is influenced by the presence of comorbid stroke risk factors. Estimating risk of thromboembolism is an important first step in the management of patients with atrial fibrillation. CHA2DS2-VASc score is a useful clinical tool that can aid decision making in antithrombotic management of patients with atrial fibrillation. Only truly low-risk patients with atrial fibrillation (CHA2DS2-VASc score = 0) will not benefit from oral anticoagulation.

Original languageEnglish
Title of host publicationStroke Prevention in Atrial Fibrillation
PublisherFuture Medicine
Pages11-28
Number of pages18
ISBN (Print)978-1-78084-036-9, 978-1-78084-118-2
DOIs
Publication statusPublished - 1 Oct 2012

Fingerprint Dive into the research topics of 'Stroke risk assessment in atrial fibrillation'. Together they form a unique fingerprint.

Cite this